Company / Current Assets
MoonLake Immunotherapeutics Current Assets History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$421.7M
FY2025
5-year range
$9.6M / $514.2M
FY2021-FY2025
Trend
-11.1%
vs FY2024
Sector context
#128 of 213
Health Care
What the data says
At $422M, MoonLake Immunotherapeutics's current assets ranks #128 of 213 in the Health Care sector. Declined from $514M to $422M over the past 2 years.
Based on SEC 10-K filings.
$422M in FY2025 with a 5-year CAGR of +204.2%.
Declined from $514M to $422M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +76.6%
- 5-Year CAGR
- +204.2%
- 10-Year CAGR
- -
Sector benchmark
#128 of 213 in Health CareTop 60% of 213This company $421.7M Sector average $2.5B
▼
-83.3% below sector average
Key checks
Key Insights
- 5-year CAGR of +204.2%, indicating consistent growth.
- In FY2025, current assets decreased 11.1% year-over-year.
- Ranks #128 out of 213 companies in the Health Care sector.
- Peak current assets was recorded in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -0.09 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $421.7M | -11.1% |
| FY2024 | $474.3M | -7.8% |
| FY2023 | $514.2M | +572.0% |
| FY2022 | $76.5M | +694.0% |
| FY2021 | $9.6M | +495.2% |
| FY2020 | $1.6M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026